Juliusson G, Gahrton G
Cancer Genet Cytogenet. 1985 Dec;18(4):307-13. doi: 10.1016/0165-4608(85)90152-9.
Cytogenetic analysis was performed in B-cell mitogen-stimulated leukemic cell cultures from 55 patients with chronic B-lymphocytic leukemia. Clonal chromosomal aberrations were found in the cells of 33 patients, whereas 10 patients were cytogenetically normal. For 12 patients, too few metaphases were found to enable proper evaluation of the karyotype. The patients were subdivided into four groups according to the ratio between the number of metaphases with abnormal and normal chromosome patterns: AA, patients with only abnormal (A) metaphases; A/N high, patients with both abnormal and normal (NN metaphases and an A/N ratio greater than 0.5; A/N low, patients with an A/N ratio less than 0.5; NN, patients with only normal metaphases. In a log rank analysis, increasing A/N ratio was significantly associated with poor survival (p = 0.025). Four AA patients had a median survival of 6 months, whereas the 5-year probability of survival was 0.62 for the A/N high group, 0.92 for the A/N low group, and 1.0 for the NN group.
对55例慢性B淋巴细胞白血病患者经B细胞有丝分裂原刺激的白血病细胞培养物进行了细胞遗传学分析。在33例患者的细胞中发现了克隆性染色体畸变,而10例患者细胞遗传学正常。有12例患者找到的中期分裂相太少,无法对核型进行恰当评估。根据具有异常和正常染色体模式的中期分裂相数量之比,将患者分为四组:AA组,只有异常(A)中期分裂相的患者;A/N高组,既有异常又有正常(N)中期分裂相且A/N比值大于0.5的患者;A/N低组,A/N比值小于0.5的患者;NN组,只有正常中期分裂相的患者。在对数秩分析中,A/N比值增加与生存不良显著相关(p = 0.025)。4例AA组患者的中位生存期为6个月,而A/N高组的5年生存概率为0.62,A/N低组为0.92,NN组为1.0。